Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sclerosing mesenteritis. Response to cyclophosphamide.

R W Bush, S P Hammar, R H Rudolph

    Archives of Internal Medicine
    |March 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Performance and ergonomic characteristics of expert surgeons using a face-mounted display during virtual reality-simulated laparoscopic surgery: an electromyographically based study.

    Surgical endoscopy·2006
    Same author

    Well-differentiated papillary mesothelioma.

    The American journal of surgical pathology·2001
    Same author

    Malignant mesothelioma from neighborhood exposure to anthophyllite asbestos.

    American journal of industrial medicine·2001
    Same author

    Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. 1970.

    Journal of hematotherapy & stem cell research·2001
    Same author

    Pulmonary atypical carcinoid: predictors of survival in 106 cases.

    Human pathology·2000
    Same author

    Asbestos in extrapulmonary sites: omentum and mesentery.

    Chest·2000
    Same journal

    Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

    Archives of internal medicine·2017
    Same journal

    Occult Carbon Monoxide Poisoning-Reply.

    Archives of internal medicine·2017
    Same journal

    Acquired Immune Deficiency Syndrome-Reply.

    Archives of internal medicine·2017
    Same journal

    Heparin Side Effects-Reply.

    Archives of internal medicine·2017
    Same journal

    Humanizing primary care medicine begins with stress.

    Archives of internal medicine·2017
    Same journal

    Legend omitted and number misrepresented.

    Archives of internal medicine·2013
    See all related articles

    Aggressive sclerosing mesenteritis can be life-threatening. Early immunosuppressive therapy with cyclophosphamide offers a dramatic, lasting improvement for patients, especially when tubuloreticular structures are present.

    Area of Science:

    • Gastroenterology
    • Pathology
    • Immunology

    Background:

    • Sclerosing mesenteritis is a rare, potentially aggressive inflammatory condition affecting the mesentery.
    • Characterized by progressive fibrosis, it can lead to significant morbidity and mortality.
    • The presence of tubuloreticular structures suggests a potential link to autoimmune processes.

    Observation:

    • Two patients presented with aggressive sclerosing mesenteritis, featuring extensive retroperitoneal disease.
    • One patient exhibited tubuloreticular structures, an ultrastructural finding linked to autoimmune conditions and cyclophosphamide responsiveness.
    • Both cases demonstrated a severe, life-threatening clinical course.

    Findings:

    • Aggressive immunosuppressive therapy utilizing cyclophosphamide was initiated in both patients.

    Related Experiment Videos

  • Prompt and dramatic clinical improvement was observed in both cases following cyclophosphamide treatment.
  • No recurrence of the disease was noted during the follow-up period.
  • Implications:

    • Cyclophosphamide is a highly effective treatment for aggressive sclerosing mesenteritis.
    • Early intervention with cyclophosphamide is recommended, particularly in cases with tubuloreticular structures.
    • This approach may significantly alter the prognosis of this rare and severe disease.